Safety Assessment
Penicillinase from Bacillus subtilis has not been granted Generally Recognized as Safe (GRAS) status by the FDA, indicating that it has not undergone the formal GRAS determination process. However, the enzyme has an excellent safety record with zero reported adverse events to the FDA and zero associated recalls in FDA databases. The safety profile of penicillinase is supported by several factors: the enzyme is a natural protein that is denatured and inactivated during food processing, Bacillus subtilis is a non-pathogenic organism with a long history of safe use in food applications, and the enzyme's function is highly specific to beta-lactam structures, limiting off-target effects. As an enzyme used as a processing aid, penicillinase is typically inactivated during cooking or industrial heat treatment and does not persist in the final food product. Individuals with penicillin allergies should not have adverse reactions to residual penicillinase itself, though the primary purpose of using the enzyme is to eliminate penicillin residues that could trigger such reactions.
Regulatory Status
While penicillinase from Bacillus subtilis has not received FDA GRAS status, it is permitted for use in certain food applications under FDA regulations as a processing aid. The enzyme is recognized in various regulatory jurisdictions and is included in some food safety standards. Its use is typically limited to specific applications where penicillin residue removal is necessary, such as in dairy processing. The lack of GRAS status does not indicate safety concerns but rather reflects that manufacturers have not submitted or completed the formal GRAS notification process with the FDA. Regulatory oversight remains through existing food safety frameworks.
Key Studies
Scientific literature on penicillinase application in food processing demonstrates the enzyme's effectiveness at degrading penicillin residues in milk and dairy products. Studies have shown that the enzyme can reduce penicillin concentrations to undetectable levels under appropriate processing conditions. Research on Bacillus subtilis-derived enzymes indicates a favorable safety profile with no documented pathogenic properties. The enzymatic specificity of penicillinase for beta-lactam structures has been well-characterized in pharmaceutical and food science literature. However, specific peer-reviewed studies in prominent food safety journals dedicated exclusively to this particular strain and application in food systems are limited in publicly available literature.